» Articles » PMID: 24573608

Genetic Unraveling of Colorectal Cancer

Overview
Journal Tumour Biol
Publisher Sage Publications
Specialty Oncology
Date 2014 Feb 28
PMID 24573608
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Colorectal cancer is a common disease in both men and women (being the third most common cancer in men and the second most common among women) and thus represents an important and serious public health issue, especially in the western world. Although it is a well-established fact that cancers of the large intestine produce symptoms relatively earlier at a stage that can be easily cured by resection, a large number of people lose their lives to this deadly disease each year. Recent times have seen an important change in the incidence of colorectal cancer in different parts of the world. The etiology of colorectal cancer is multifactorial and is likely to involve the actions of genes at multiple levels along the multistage carcinogenesis process. Exhaustive efforts have been made out in the direction of unraveling the role of various environmental factors, gene mutations, and polymorphisms worldwide (as well as in Kashmir-"a valley of gastrointestinal cancers") that have got a role to play in the development of this disease so that antitumor drugs could be developed against this cancer, first, and, finally, the responsiveness or resistance to these agents could be understood for combating this global issue.

Citing Articles

Polymorphisms of nucleotide excision repair genes associated with colorectal cancer risk: Meta-analysis and trial sequential analysis.

Yi C, Li T, Shen Y, Wang P, Dai L, Shi J Front Genet. 2022; 13:1009938.

PMID: 36386844 PMC: 9659581. DOI: 10.3389/fgene.2022.1009938.


Colorectal Cancer: A Review of Carcinogenesis, Global Epidemiology, Current Challenges, Risk Factors, Preventive and Treatment Strategies.

Hossain M, Karuniawati H, Jairoun A, Urbi Z, Ooi D, John A Cancers (Basel). 2022; 14(7).

PMID: 35406504 PMC: 8996939. DOI: 10.3390/cancers14071732.


Contribution of Murine Double Minute 2 Genotypes to Colorectal Cancer Risk in Taiwan.

Yueh T, Hung Y, Shih T, Wu C, Wang S, Lai Y Cancer Genomics Proteomics. 2018; 15(5):405-411.

PMID: 30194081 PMC: 6199579. DOI: 10.21873/cgp.20099.


The Contribution of Genotypes to Colorectal Cancer Susceptibility in Taiwan.

Yueh T, Wu C, Hung Y, Chang W, Fu C, Pei J Cancer Genomics Proteomics. 2018; 15(3):207-212.

PMID: 29695403 PMC: 5971013. DOI: 10.21873/cgp.20079.


The association between CCND1 G870A polymorphism and colorectal cancer risk: A meta-analysis.

Xie M, Zhao F, Zou X, Jin S, Xiong S Medicine (Baltimore). 2017; 96(42):e8269.

PMID: 29049220 PMC: 5662386. DOI: 10.1097/MD.0000000000008269.


References
1.
Sameer A, Shah Z, Abdullah S, Chowdri N, Siddiqi M . Analysis of molecular aberrations of Wnt pathway gladiators in colorectal cancer in the Kashmiri population. Hum Genomics. 2011; 5(5):441-52. PMC: 3525962. DOI: 10.1186/1479-7364-5-5-441. View

2.
Nissar S, Lone T, Banday M, Rasool R, Chowdri N, Parray F . Arg399Gln polymorphism of XRCC1 gene and risk of colorectal cancer in Kashmir: A case control study. Oncol Lett. 2013; 5(3):959-963. PMC: 3576209. DOI: 10.3892/ol.2013.1104. View

3.
Sameer A, Chowdri N, Syeed N, Banday M, Shah Z, Siddiqi M . SMAD4--molecular gladiator of the TGF-beta signaling is trampled upon by mutational insufficiency in colorectal carcinoma of Kashmiri population: an analysis with relation to KRAS proto-oncogene. BMC Cancer. 2010; 10:300. PMC: 2927996. DOI: 10.1186/1471-2407-10-300. View

4.
Tamm I, Wang Y, Sausville E, Scudiero D, Vigna N, Oltersdorf T . IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer Res. 1998; 58(23):5315-20. View

5.
Gupta R, DuBois R . Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2. Nat Rev Cancer. 2002; 1(1):11-21. DOI: 10.1038/35094017. View